Novel diagnostic and prognostic biomarkers in esophageal cancer

By Plum Patrick S   Bollschweiler Elfriede   Hölscher Arnulf H   Warnecke-Eberz Ute  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 6, 2013-11 ,pp. : 557-571

Informa Healthcare

Access to resources Recommend Favorite

DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer

By Gyparaki Melina-Theoni   Basdra Efthimia   Papavassiliou Athanasios  

Journal of Molecular Medicine, Vol. 91, Iss. 11, 2013-11 ,pp. : 1249-1256

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer

By Prager Alisa J   Peng Cynthia R   Lita Elena   McNally Debbie   Kaushal Aradhana   Sproull Mary   Compton Kathryn   Dahut William L   Figg William D   Citrin Deborah   Camphausen Kevin A  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 831-841

Future Medicine

Access to resources Recommend Favorite

The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1406-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite